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Abstract We previously showed that autocrine tumor necrosis 
factor (TNF) production in the TNF-sensitive L929sA fibrosar-
coma cell line induced TNF resistance, which is correlated with 
downmodulation of both TNF receptors on the cell surface. We 
now analyzed whether autocrine TNF production also interfered 
with intracellular TNF signaling pathways. The L929sA-CAT-
R55i cell line, in which cell death can be induced by controlled 
cytoplasmic expression of a trimeric fusion protein between 
chloramphenicol acetyltransferase and the intracellular domain 
of TNF-R55 (CAT-R55Í), was supertransfected with the murine 
TNF gene. Expression of the latter conferred resistance to cell 
death induced by exogenous TNF, while cytotoxicity induced by 
CAT-R55Í was not impaired. This demonstrates that autocrine 
TNF did not induce intracellular mechanisms that block TNF 
signaling leading to cell death. Thus the induction of TNF 
resistance via autocrine TNF production in L929sA cells is solely 
due to downmodulation of TNF receptors on the cell surface. 
© 1997 Federation of European Biochemical Societies. 
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1. Introduction 
The pleiotropic cytokine tumor necrosis factor (TNF) is 
mainly produced by macrophages, but a wide variety of other 
cells can also produce TNF. TNF exerts a whole spectrum of 
biological activities, depending on the cell type, via interaction 
with well-characterized transmembrane TNF receptors with 
Mrs of 55 kDa (TNF-R55) and 75 kDa (TNF-R75) [1]. 
TNF signaling is initiated by receptor clustering after inter-
action with trimeric TNF, followed by the recruitment of 
multiple factors to the TNF receptor [2]. TNF is cytotoxic 
to many types of tumor cells, especially in synergy with inter-
feron-y (IFN-y). However, several tumor cell lines are resistant 
to the cytotoxic effect of TNF, and some of them produce 
autocrine TNF [3-6]. Moreover, transfection of TNF-sensitive 
cell lines with an exogenous TNF gene, under control of a 
constitutive promoter, confers resistance to TNF-mediated 
cytotoxicity [7,8]. We previously demonstrated that TNF re-
sistance caused by autocrine TNF production in the TNF-
sensitive L929sA cell line is correlated with downmodulation 
of the TNF receptors on the plasma membrane [8]. We now 
investigated whether intracellular TNF resistance mechanisms 
are also involved in this TNF unresponsiveness of TNF-pro-
ducing L929sA cells. In order to answer this question we used 
a cell line in which intracellular TNF effects can be mimicked 
without actual need for TNF itself or its transmembrane re-
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ceptor. In this cell line, called L929sA-CAT-R55i, expression 
of a cytosolic fusion protein of chloramphenicol acetyltrans-
ferase (CAT) and the intracellular domain of TNF-R55 
(CAT-R55Í) is under control of the type I IFN-inducible 
Mx promoter. Expression of trimeric CAT enforces clustering 
of the intracellular domain of the TNF receptor, which leads 
to activation of the nuclear factor KB, production of interleu-
kin-6 and cell death [2,9]. The cell line was supertransfected 
with the murine TNF gene in order to determine the intra-
cellular sensitivity caused by controlled expression of the 
CAT-R55Í fusion protein in a cell resistant to exogenous 
TNF. 
2. Materials and methods 
2.1. Cell lines and cell culture 
The flbrosarcoma cell lines L929sA [8] and L929sA-CAT-R55i [9] 
were cultured as previously described. These cell lines were repeatedly 
screened for mycoplasma with a DNA-fluorochrome assay and were 
found to be negative. 
2.2. Cytokines and antisera 
Purified Escherichia co/Z-derived murine TNF was produced in our 
laboratory and had a specific biological activity of 2 x10s IU/mg. 
Recombinant murine IFN-ß was also produced in our laboratory 
and had a specific activity of 3X108 U/ml as determined on murine 
cells in an L929/vesicular stomatitis virus assay. Murine IFN-y was 
produced in Chinese hamster ovary cells and had a concentration of 
105 U/ml. Polyclonal rabbit antiserum against murine TNF-R55 and 
TNF-R75 was a kind gift of Dr. W.A. Buurman (University of Lim-
burg, Maastricht, The Netherlands). 
2.3. Plasmids and transfection 
pSV23S-mTNF, encoding the murine TNF gene driven by the con-
stitutive SV40 early promoter [10], and pPHT, encoding the hygro-
mycin-resistant (hygror) gene, were stably transfected in L929sA-
CAT-R55Í cells. The protocol involved improved DNA-calcium phos-
phate coprecipitation as described previously [8]. 
2.4. Flow fluorocytometry 
The presence of TNF-R55 or TNF-R75 on the cell membranes was 
determined by incubating cells for 1 h at 4°C with polyclonal rabbit 
antiserum against TNF-R55 or TNF-R75 (1 ug antiserum per 4X 105 
cells in 200 |il), followed by incubation for 1 h at 4°C with biotiny-
lated donkey anti-rabbit polyclonal antiserum (Amersham Life Sci-
ence, Amersham, UK), and by subsequent incubation for 1 h at 4°C 
with phycoerythrin-conjugated streptavidin. Soluble TNF was re-
moved from the cell surface receptors by prior acidic treatment for 
3 min at room temperature with glycine-HCl buffer (50 mM, contain-
ing 150 mM NaCl, pH 3.0). Analyses were performed by flow fluo-
rocytometry using a Coulter Epics 753 equipped with an argon-ion 
laser (Coulter, Hialeah, FL). 
2.5. Determination of sensitivity to exogenous TNF or intracellular 
CAT-R55Í expression 
TNF sensitivity was determined as previously described [6]. The 
sensitivity of cells to IFN-ß-induced CAT-R55i expression was ana-
lyzed as follows. Cells were seeded in 96-well plates in 100 |xl of 
medium at a concentration of 2X104 cells per ml. 12-18 h later, 
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CAT-R55Í was induced by adding 1000 U/ml IFN-ß in 100 ul for an 
incubation period of up to 24 h. Surviving cells were stained with 3-
(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide and as-
sayed colorimetrically [11]. 
2.6. Determination of expression of the CAT-R55Í fusion product 
Confluent monolayers of L929sA-CAT-R55i transfectants were 
treated with 1000 U/ml IFN-ß or were left untreated. After 4.5 h, 
cells were washed with phosphate-buffered saline, pelleted, and lysed 
on ice with phosphate-buffered saline containing 1% 3-[(3-cholamido-
propyl)dimethylammonio]-l-propanesulfonic acid, 1 mM ethylenedi-
aminetetraacetate and 10 mM Pefabloc (Pentapharm, Basel, Switzer-
land). Cleared lysates were assayed for CAT enzymatic activity. The 
assay mixture, a total volume of 90 ul, contained 1 uCi of [14C]deoxy-
chloramphenicol, 20 u,g of protein extract. These reagents were pre-
incubated for 5 min at 37°C and the reaction was started by addition 
of 10 ul of 9 mM acetyl coenzyme A. The reaction lasted 2.5 h and 
was stopped by addition of 1 ml ice-cold ethyl acetate which was used 
to extract the chloramphenicol. The organic layer was dried and taken 
up in 20 |xl ethyl acetate; 5 ul of this solution was spotted on silica gel 
thin-layer plates and resolved with chloroform/methanol (95:5; as-
cending). Visualization of the separated acetylated forms was obtained 
by Phosphor Image Quantification (Molecular Dynamics, Sunnyvale, 
CA). 
3. Results and discussion 
Previously, we reported that transfection of L929sA cells 
with the murine TNF gene led to autocrine TNF production 
and TNF resistance, which was correlated with downmodula-
tion of the TNF receptors on the plasma membrane [8]. Now 
we analyzed whether autocrine TNF also affects intracellular 
TNF signaling pathways leading to cell death. Hence we de-
termined the effect of autocrine TNF production on the cyto-
toxicity induced by intracellular expression of a chimeric 
CAT-R55Í protein, which clusters the intracellular domains 
of TNF-R55. We supertransfected the TNF gene in the 
L929sA-CAT-R55i cell line, previously transfected with the 
CAThTNFR55i fusion gene under control of the Mx pro-
moter inducible by IFN type I (IFN-a or IFN-ß). IFN-a-
induced intracellular expression of CAT-R55Í protein complex 
leads to cell death in L929sA-CAT-R55i cells [2,9]. After sta-
ble transfection of L929sA-CAT-R55i with the hygro1 gene 
alone or in combination with the TNF gene, hygror colonies 
were obtained and tested for their TNF production, TNF 
sensitivity and finally for their sensitivity to IFN-ß treatment 
which activates the expression of CAT-R55Í leading to cell 
death. 
The production of TNF in the culture supernatant of 10 
L929sA-CAT-R55i TNF transfectants tested varied between 
0.7 and 70 IU TNF/ml. No secreted TNF was detected in the 
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Fig. 1. TNF sensitivity of L929sA-CAT-R55i cells. Cells were trans-
fected with the hygro1 gene alone ( A ) or cotransfected with the 
TNF gene (D). Sensitivity was determined after 24 h in the presence 
of TNF. 
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Fig. 2. Flow cytometric analysis of TNF-R55 and TNF-R75 expres-
sion on L929sA-CAT-R55i cells. Cells were transfected with the 
hygro1 gene alone (A) or cotransfected with the TNF gene (B). Cells 
were then treated with antiserum directed against TNF-R55 or 
TNF-R75 and secondary antibody (full line) or with secondary anti-
body alone (broken line). 
alone. Autocrine TNF production, as low as 0.7 IU TNF/ml, 
protected L929sA-CAT-R55i TNF transfectants completely 
against the cytotoxic effect of TNF, while L929sA-CAT-
R55i cells transfected with the hygror gene alone remained 
TNF-sensitive (Fig. 1). The representative transfectant used 
in all further experiments produced 15 IU TNF/ml. In order 
to determine whether the induction of TNF resistance was 
correlated with downmodulation of the TNF receptors on 
the cell surface, as is the case for L929sA TNF transfectants, 
the expression level of both TNF receptor types in L929sA-
CAT-R55Í TNF transfectants was measured by flow fluoro-
cytometric analysis. As shown in Fig. 2, in contrast to hygror 
control transfectants, no TNF-R55 and TNF-R75 molecules 
could be detected on TNF-producing L929sA-CAT-R55i 
transfectants. Even after pretreatment with glycine-HCl buf-
fer, meant to remove receptor-bound TNF from the TNF 
receptors [8], no TNF receptor molecules could be detected 
on TNF-producing transfectants. Taken together, these re-
sults demonstrate that L929sA-CAT-R55i cells supertrans-
fected with the TNF gene behave like parental L929sA cells 
transfected with the TNF gene as described previously [8]. But 
transfection of the TNF gene in L929sA-CAT-R55i cells did 
not affect inducible CAT-R55Í expression (Fig. 3). 
In order to investigate whether autocrine TNF production 
could also protect against TNF cytotoxicity independently of 
transmembrane TNF receptors, we determined whether IFN-
ß-induced expression of a trimeric CAT-R55Í fusion protein 
could still induce cell killing. As shown in Fig. 4, cell death 
was evident 6 h after IFN-ß administration and followed very 
comparable time kinetics both in non-TNF-producing and in 
TNF-producing L929sA-CAT-R55i transfectants. To rule out 
the possibility that the sensitivity of these transfectants to 
IFN-ß was independent of CAT-R55Í expression and was 
mediated by IFN-ß itself, the effect of IFN-ß treatment was 
investigated on parental L929sA and TNF-producing L929sA 
cells, both transfected with the hygror gene. No cell death was 
induced by IFN-ß administration in these transfectants, sup-
porting the conclusion that the observed sensitivity of 
L929sA-CAT-R55i transfectants to IFN-ß was due to CAT-
R55i expression (Fig. 5). To further establish that IFN-ß-in-
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Fig. 5. Determination of sensitivity to IFN treatment of L929sA or 
L929sA-CAT-R55i cells. Cells were transfected with the hygro1 gene 
alone or cotransfected with TNF, and were subjected to a 24-h 
treatment with 1000 U/ml of IFN-ß (open bars), IFN-y (filled bars), 
or IFN-ß in combination with actinomycin D (hatched bars). 
Fig. 3. Determination of IFN-ß-inducible CAT-R55Í expression in 
L929sA-CAT-R55i cells. Cells were transfected with the hygror gene 
alone or cotransfected with TNF as described in Section 2. 
duced cell killing in L929-CAT-R55Í transfectants could be 
ascribed to Mx promoter-driven expression of the CAT-
R55i cytotoxic fusion product, the effect on cell survival of 
IFN-y, which induces many effects similar to those observed 
with type I IFNs, but which cannot activate the Mx promoter, 
was investigated. Moreover, considering that most IFN effects 
are protein synthesis-dependent, we also tested, as a control, 
treatment with IFN-ß combined with actinomycin D. IFN-y 
treatment did not induce cell death in any of the cell lines 
tested (Fig. 5), while reduced cytotoxicity was observed in 
L929sA-CAT-R55i transfectants after a combined treatment 
with IFN-ß and actinomycin D compared with an IFN-ß 
treatment alone (Fig. 5). These results and the fact that 
CAT-R55Í expression could only be detected after IFN-ß 
treatment indicate that IFN-ß-induced cytotoxicity in 
L929sA-CAT-R55i transfectants was indeed dependent on 
Mx promoter-induced expression of the CAT-R55Í fusion 
product. It may also be mentioned that IFN-ß-induced ex-
pression of CAT alone does not lead to cell killing in 
L929sA cells (data not shown). This observation confirms 
that the occurrence of cell death after CAT-R55Í expression 
is due to signalization via the clustered intracellular domains 
of TNF-R55. 
Taken together, our results clearly demonstrate that auto-
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Fig. 4. Time kinetics of cell death obtained by IFN-ß-induced CAT-
R55i expression. Cytotoxicity on L929sA-CAT-R55i cells transfected 
with the hygror gene alone ( A ) or cotransfected with TNF (o) was 
measured at different time points after treatment with 1000 U/ml of 
IFN-ß. 
crine TNF production confers resistance against the cytotoxic 
effect of exogenous TNF via downmodulation of the TNF 
receptor on the cell surface. Receptor downmodulation pre-
sumably is an intracellular process occurring at the level of de 
novo synthesis. Considering that receptor downregulation oc-
curs only with an active TNF molecule, and not with an 
inactive TNF mutant having highly reduced TNF receptor-
binding capacity [8], an accurate interaction between the TNF 
receptor and TNF may lead to intracellular retention of the 
TNF receptor. If TNF receptor clustering occurs intracellu-
larly, triggering of the signaling pathway may be expected, 
resulting in cell killing. This is, however, not the case, since 
TNF-producing L929 cells do not die. The phenomenon 
might be explained by a mechanism involving autocrine 
TNF which induces TNF resistance proteins or other protec-
tion mechanisms blocking the TNF signaling pathway leading 
to cell death. We here show, however, that cell killing can still 
occur in TNF-producing L929sA cells by TNF signalization 
induced via expression of clustered intracellular TNF receptor 
domains (CAT-R55Í). This observation implies that autocrine 
TNF does not induce or select for intracellular TNF protec-
tion mechanisms. In conclusion, the data presented in this 
report demonstrate in a direct way that the acquisition of 
unresponsiveness to TNF cytotoxicity via autocrine TNF pro-
duction is solely a consequence of the disappearance of TNF 
receptor molecules on the cell surface, by which TNF-produc-
ing L929sA cells become blind to the effects of this cytokine. 
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